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Abstract
Although several efficacious treatments for Posttraumatic Stress Disorder (PTSD) exist, these
treatments are currently underutilized in clinical practice. To address this issue, research must
better identify barriers to dissemination of these treatments. This study investigated patient
preferences for PTSD treatment given a wide range of treatment options in an analogue
sample. One hundred and sixty individuals, with varying degrees of trauma history, were asked
to imagine themselves undergoing a trauma, developing PTSD, and seeking treatment.
Participants evaluated seven different treatment descriptions which depicted treatment options
that they might encounter in a clinical setting. Participants rated their most and least preferred
treatments along with their personal reactions to and the perceived credibility of each treatment.
Participants also completed a critical thinking skills questionnaire. Participants predominantly
chose exposure or another variant of cognitive-behavioral therapy as their most preferred
therapy, and those who chose exclusively empirically supported treatments evidenced higher
critical thinking skills. The present study contributes to a growing literature indicating that
patients may be more interested in these therapies than indicated by utilization rates. The
problem of underutilization of empirically supported treatments for PTSD in clinical practice may
be due to therapist factors.
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An Analogue Study of Patient Preferences for Exposure versus Alternative Treatments for Post
Traumatic Stress Disorder
1.1 Introduction
Strong empirical support exists for the use of exposure to treat posttraumatic stress
disorder (PTSD: Foa, Keane, & Friedman, 2000). Despite this, research suggests that
exposure remains underutilized in clinical practice (Becker, Zayfert, & Anderson, 2004; Foy et
al., 1996; Rosen et al., 2004). For example, Becker et al. found that 83% of 207 licensed
psychologists reported not using imaginal exposure to treat PTSD. Even among those who had
been formally trained in exposure for PTSD (n = 59), 46% reported treating none of their
patients with imaginal exposure, and only 15% reported routine use of exposure. Rosen et al.
similarly found that less than 20% of PTSD experts in a VA setting reported routine use of
exposure to treat PTSD.
Clinical underutilization of empirically supported treatments (EST), such as exposure,
may result from therapist factors (e.g., lack of training, perceptions about the treatment), patient
factors (e.g., credibility of treatment rationale, anticipation of discomfort), or an interaction of the
two. An interaction might involve a patient expressing concern about an EST and a therapist,
who is also uncomfortable with the EST, using the patient’s concern to justify choosing an
alternate treatment instead of reviewing the rationale or exploring the patient’s concerns.
Although limited, research exploring therapist factors and use of exposure for PTSD
currently highlights the role therapists may play in underutilization. For example, almost three
quarters of the psychologists in Becker et al. (2004) reported that lack of training influenced their
non-use of exposure. They also reported a high rate of perceived contraindications to exposure
and concerns about complications resulting from use of exposure. Similarly, Najavits (2006)
found that, compared to a present focused skills based intervention, clinician participants at a
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workshop on the treatment of PTSD and substance use disorders rated an exposure-based
intervention as significantly less appealing to conduct. The clinicians also rated exposure as
less important for dual diagnosed PTSD patients and less safe in a group format, in an
individual format, and when conducted as a short-term intervention (e.g., four months or less).
In addition, participants endorsed greater concerns about exposure requiring specialized
training. Taken together, results suggest that both lack of training and clinical concerns about
exposure for PTSD may decrease therapists’ use.
The limited research exploring patient factors, however, has produced differing results.
For example, Zoellner, Feeny, Cochran, and Pruitt (2003) conducted an analogue study
exploring patient preference for exposure versus medication. Female students with varying
degrees of trauma history read a description of a traumatic event and subsequently indicated
what they would do if they experienced that event. Given a forced choice of exposure,
sertraline, or no treatment, participants overwhelmingly chose exposure. Exposure also was
rated as more credible and produced more positive personal reactions. Results of this analogue
study subsequently were largely replicated in a patient population (Feeny & Zoellner, 2004). The
findings of this second study provide some support for the initial analogue approach.
Although the Zoellner et al. (2003) and Feeny & Zoellner (2004) studies provide
preliminary evidence that patients may have fewer concerns about exposure for PTSD as
compared to therapists, the forced choice results also can be interpreted as indicating that
patients prefer psychotherapy over medication. Thus, these studies do not indicate the degree
to which patients might select exposure as the treatment of choice when offered a range of
psychotherapy options.
In an online analogue survey, Tarrier, Liversidge, and Gregg (2006) evaluated potential
patient attitudes to a range of psychological PTSD interventions. Students rated 14
psychological treatments on a variety of scales and then ranked these treatments from most to
least preferred. Tarrier et al. selected their interventions based on the PTSD treatment literature.
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The interventions included: psycho-education, imaginal exposure, in vivo exposure, virtual
reality exposure, guided imagery, cognitive therapy, cognitive therapy plus exposure, stress
management, eye movement desensitization and reprocessing therapy (EMDR), computer
based treatment including exposure and stress management, psychodynamic therapy, Etherapy conducted with a therapist over the internet, group therapy including exposure and
stress management, and family therapy including problem solving. Cognitive therapy emerged
as the therapy of choice; treatments involving exposure also were highly ranked (i.e., included in
three of the five top ranked treatments) despite receiving high ratings on a scale assessing
projected discomfort. All of the five highest ranking treatments in this study were presented as
efficacious, suggesting that analogue patients seem attuned to treatment efficacy and appear
willing to tolerate discomfort when deciding to enroll in a particular therapy. Interestingly, EMDR,
which has some significant empirical support and appears popular among therapists, received
some of the lowest ratings, suggesting that patients also may consider factors other than
efficacy.
The results of Tarrier et al. (2006) support those found by Zoellner et al. (2003) and
Feeny and Zoellner (2004), and suggest that exposure for PTSD may be of greater interest to
patients than indicated by its current utilization in clinical practice. One limitation in the Tarrier et
al. study, however, was the exclusion of a medication comparison. Thus, none of the studies
listed above offered participants a range of psychotherapy options along with a medication
option – a choice which theoretically should be available to patients in clinical settings.
A second potential limitation of Tarrier et al. is the extensive focus on variants of
cognitive behavioral therapy (CBT). For example, depending on how one classifies EMDR,
either 10 or 11 of the treatment options appear to be variants of CBT. In addition, over 50% of
the interventions included exposure in some form or another. This is potentially problematic for
two reasons. First, exposure may have been more highly rated because participants were
influenced by its frequent appearance in the treatment descriptions. Second, although the
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inclusion of many forms of CBT makes sense given that a) Tarrier et al. based their selection of
treatments on the scientific PTSD treatment literature and b) CBT dominates this literature, it is
unclear whether the scientific literature matches the range of treatment options to which
individuals with PTSD may be exposed. For example, the internet often serves as a source of
information for individuals with psychological disorders. During a quick internet search of “PTSD
treatment,” we found a website promoting “promising” PTSD treatments. These approaches
consisted of a series of interventions that have been labeled the “power therapies” (see Devilly,
2005 for in depth discussion). Power therapies consist of interventions that typically rest on
questionable theories and are associated with extensive and unsupported reports of
extraordinary success rates and rapid effects (Devilly). With the exception of EMDR, which has
received empirical scrutiny and support (Rothbaum, Astin, & Marsteller, 2005), most power
therapies have not been subjected to rigorous scientific examination. Power therapies represent
a concerning treatment option because their impressive, yet largely unsupported, claims may be
attractive to traumatized individuals and lure them away from treatment with greater empirical
support.
The purpose of the present study was threefold. First, we sought to extend and combine
the analogue approaches of Zoellner et al. (2003) and Tarrier et al. (2006) by including both a
range of psychological interventions for PTSD and a medication option. Second, we sought to
include some potentially troublesome interventions (i.e., power therapies) that traumatized
individuals might encounter. Tarrier et al. included one power therapy, EMDR, in their study.
Among the power therapies, however, EMDR has the greatest amount of empirical support and
claims regarding its efficacy largely have been scaled back over time (Devilly, 2005). Therefore,
in addition to EMDR, we selected a power therapy, Thought Field Therapy (TFT), with strong
claims that are supported by substantially less empirical evidence (see McNally, 2001 for review
of TFT). To further explore the degree to which analogue PTSD patients might be drawn to
interventions lacking solid scientific foundations, we also developed our own intervention for
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PTSD, which we based on real therapy product. The description of this fabricated intervention
was designed to make an intentionally absurd treatment, which in essence proposed that a blue
stuffed creature could be used to treat PTSD, sound psychologically viable.
In a recent study, Sharp and Herbert (2006) found that professional psychologists who
used techniques drawn from power therapies scored lower on a measure of critical thinking
skills compared to psychologists who relied to a greater degree on techniques drawn from
ESTs. Thus, the third goal of this study was to conduct a preliminary exploratory investigation as
to whether or not critical thinking skills were similarly associated with treatment choice in
analogue patients.
Although exposure was highly rated in the Zoellner et al. (2003), Feeny and Zoellner
(2004), and Tarrier et al. (2006) studies, we hypothesized that exposure would not be highly
chosen when a greater number of non-CBT psychotherapy options were offered in addition to a
medication option. This hypothesis was based, in large part, on the low-utilization of exposure in
clinical practice. In addition, based on Sharp and Herbert’s (2006) study, we hypothesized that
individuals who chose empirically supported treatments (e.g., exposure) over other therapies
with less empirical support would evidence better critical thinking skills.
1.2 Method
1.2.1 Participants
One hundred and sixty students recruited from the psychology human subject pool at a
small university participated in this study. The study was approved by the Trinity University
Institutional Review Board, and students received course credit for their participation. Thirtyeight percent of participants were male and sixty-two percent of participants were female;
participants had an average age of 18.64 (SD = .73).
1.2.2 Materials
1.2.2.1 Treatment Descriptions. Treatment descriptions outlined background information
along with procedures, typical duration, efficacy information, and possible side effects for each
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of seven treatments. The selected treatment options were designed to offer participants a
choice of interventions that varied both in terms of orientation (e.g., CBT, psychodynamic,
pharmacologic) and empirical support, so as to better represent the treatment options that
individuals with PTSD may face both in clinical settings and when conducting their own research
on the internet. We included one form of CBT that is strongly supported by the literature (i.e.,
exposure) and a pharmacological treatment also supported by research (i.e., sertraline). In
addition, because many CBT therapists blend theoretical and practical elements from different
types of CBT (Persons, 2005), we offered participants a more mixed CBT intervention that drew
heavily from Cognitive Processing Therapy (Resick & Schnicke, 1992), yet also relied on some
of the theory that often is used to support other forms of CBT for PTSD (Foa & Kozak, 1986).
Next, we included two forms of psychotherapy that appear popular among therapists
despite having less empirical support than exposure and other variants of CBT (i.e., EMDR and
psychodynamic psychotherapy). Finally, we included a power therapy with relatively little
empirical support (i.e., TFT), along with our intentionally absurd made-up therapy which we
based on an existing therapy product (i.e., My Therapy Buddy (MTB)). Treatment descriptions
from Zoellner et al.’s (2003) study were used for sertraline and exposure to facilitate comparison
of results. We generated the remaining treatment descriptions for this study. Descriptions were
designed to match those for sertraline and exposure in terms of length and style. We based
treatment information, including efficacy descriptions, on existing literature for each therapy. If
no significant scientific literature existed regarding the efficacy of a particular treatment (e.g., for
TFT or MTB), we used a statement such as “the results of this treatment speak for themselves,”
which is common claim of power therapies when marketed to lay audiences (e.g., see
www.ritacanhelp.com/newsletter/12-96.html). The treatment description for MTB was closely
based on clinical information provided at the website selling this product
(www.mytherapybuddy.com), but differed in that we proposed that MTB could be used as the
sole treatment for PTSD, a claim which is not made by the sellers of this product.
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We constructed treatment descriptions to reflect actual information that might be
presented to an individual who is seeking treatment for PTSD. The psychodynamic, EMDR, and
CBT treatment descriptions were given to colleagues who use these therapies for critique.
Because the sertraline and exposure descriptions were based on Zoellner et al. (2004), these
were not sent out for review. We also did not send the TFT description for review because we
did not have a TFT colleague with whom we could consult. As noted above, MTB was based on
the description of the treatment provided on the associated website. Several faculty members in
the psychology department, however, were asked to review the MTB description to judge
whether the description sounded psychologically viable given what the treatment actually
proposed; these colleagues also provided feedback on the TFT description. We sought to frame
all therapies as viable treatment options, and all treatment descriptions were approximately of
similar length, between 216 (EMDR) to 238 (MTB) words. See Appendix A for detailed
treatment descriptions along with word counts.
1.2.2.2 Measures. Two scales assessed participants’ opinions of each treatment: the
Credibility Scale (CS; Addis & Carpenter, 1999) and Personal Reactions to the Rationale (PRR;
Addis & Carpenter, 1999). The former scale assesses the degree to which participants find
different treatment descriptions credible. The PRR, in contrast, assesses more personal
reactions (i.e., does the individual think the treatment would work for him/her). Internal
consistency for the PRR was good with alpha coefficients ranging from a low of .81 for exposure
to a high of .95 for psychodynamic therapy in the present sample. We found similar results for
the CS (α range = .85 (exposure) - .94 (psychodynamic therapy)).
Participants also indicated their two most and two least preferred treatments from the
seven options. We chose to not have participants rank all treatment options because
participants likely have stronger opinions about treatments they most and least want, versus
those that fall in the middle. Thus, we did not want to over-interpret middle ranking positions.
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A Critical Thinking Questionnaire (CTQ: Sharp & Herbert, 2006) evaluated participants’
critical thinking skills. The CTQ was created by combining items from two established critical
thinking measures (Ennis, Millman, & Tomko, 1985; Watson & Glaser, 1994) and another critical
thinking source (Stanovich, 2001). Sharp and Herbert developed the CTQ to better target critical
thinking skills relevant to psychology. Internal consistency in the present sample for this
measure (α = .65) was somewhat lower than the internal consistency for the other measures.
We assessed psychopathology using the following self-report measures: the
Posttraumatic Stress Diagnostic Scale (PDS; Foa, Cashman, Jaycox & Perry, 1997), Beck
Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996), and State-Trait Anxiety Inventory
(STAI; Spielberger, Gorsuch, &Lushene, 1970). The PDS has satisfactory diagnostic agreement
with interview measures of PTSD (Foa et al., 1997), and it demonstrated good internal
consistency in the present sample (α = .89 for total symptom severity), as did the STAI (state α
= .92; trait α = .87) and the BDI (α = .90).
1.2.3 Procedure
After a brief introduction to the study, participants completed informed consent forms,
and then received a copy of the following trauma scenario:
Six months ago you went on a trip to New York City. After a show you decide to walk
back to your hotel. On the way back, you were held up by a man with a knife in a secluded area
on the street. He demanded your money, watch, and personal belongings and threatened that if
you would not comply immediately, he would kill you. You gave him all that he asked, but he
was not satisfied. He then began to beat and stab you violently. The next thing you knew, you
woke up in a hospital after enduring several major surgeries. Since the incident, you have been
experiencing difficulty sleeping and intrusive flashbacks where you feel as though you are back
in that situation. Any time that you are invited out at night you typically refuse because you are
afraid it might happen again. Also, you feel that you can’t talk to your friends about what
happened because they won’t understand. In addition, you have felt more on edge lately and
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are easily startled. Because your relationships and school work have suffered significantly, you
decide to seek treatment at a counseling center for your symptoms. At the counseling center
you are diagnosed with Post Traumatic Stress Disorder (PTSD). You now have a variety of
options in terms of treatment. Referral will depend on which treatment most interests you.
An experimenter asked participants to imagine themselves in this situation and then read
the scenario aloud to the participant. Participants then read treatment descriptions, which were
given to them in random order, and completed CS and PRR forms for each therapy immediately
after reading its description. After reading and evaluating all seven therapies, participants
ranked their first and second most and their two least preferred choices for referral. Participants
then completed the CTQ, followed by the BDI-II, STAI, and PDS. Participants were then
debriefed and thanked for their participation.
1.3 Results
1.3.1 PTSD Diagnoses and Trauma Histories of Participants
Eleven participants (7%) met DSM-IV criteria for PTSD as assessed by the PDS (Foa et
al., 1997). An additional 58 students (36%) reported experiencing a Criterion A traumatic event
during their lifetime, but did not currently meet criteria for PTSD. Primary Criterion A events
included motor vehicle accidents (24.6%), sexual assault (14.5%), physical assault (14.5%),
witnessing a severe motor vehicle accident, death, or assault (14.5%), natural disasters (7.2%),
terrorism, bombings, or fires (5.8%), suicide (1.4%), and other traumas (17.3%).
1.3.2 Most and Least Preferred Two Treatment Choices
Treatments were not selected equally as the number one choice by participants 2 (N
=160) = 163.40, p <.0001. Contrary to our hypothesis, exposure was the most preferred
therapy, with 51% of the sample selecting it. CBT (22%) was the second most preferred
therapy. The remaining therapies were chosen in the following order: psychodynamic therapy,
sertraline, TFT, and MTB (see Table 1). No participant selected EMDR as his/her number one
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choice. The rank order of the therapies remained unchanged when the top two choices were
combined, although the magnitude of difference between exposure and CBT decreased.
To examine the role of trauma history and likely PTSD diagnosis on treatment choice,
we examined treatment choice among participants with a trauma history and those who met
PTSD criteria based on the PDS. Of the 69 participants who met criteria for a Criterion A event
(note: this sub-sample includes participants who met criteria for PTSD), 51% again ranked
exposure as their top therapy choice. Compared to the overall sample, the rank ordering and
percentage of participants selecting each therapy was largely unchanged (see Table 1).
Eleven participants met criteria for PTSD. Exposure (36%) and CBT (27%) were again
the most preferred therapy choices, with the remainder of participants selecting sertraline and
psychodynamic therapy equally. The only time in which the rank ordering of the selections
changed occurred when we examined the top two therapy choices of individuals with likely
PTSD. Under this circumstance, participants most frequently selected CBT, followed by
exposure and psychodynamic therapy (selected equally), and sertraline (see Table 1).
Regarding the participants least preferred therapy choice, we again found that therapies
were not selected equally, 2 (N =160) = 87.69, p <.001. MTB was the most frequently selected
least preferred therapy choice (47%). EMDR, TFT and sertraline were endorsed at virtually
identical rates with between 17% and 18% of participants ranking these interventions as their
least preferred intervention. No participant selected exposure or CBT as their least preferred
treatment choice; when least and second least choices were combined only a small percentage
of participants selected exposure (1%), CBT (1%), or psychodynamic psychotherapy (3%).
1.3.3 Treatment Rationale
Mean ratings and standard deviations for the PRR and the CS for each type of treatment
are displayed in Table 2. For both scales, the three most highly rated interventions were
exposure, CBT, and psychodynamic psychotherapy. MTB and EMDR were the lowest rated
interventions for both scales. To investigate the degree to which participants rated the treatment
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rationales as equal in terms of positive personal reactions and credibility, we conducted two
within subject repeated measures analysis of variance (ANOVA) using PRR and CS scores as
the dependent variables. Because our hypotheses centered largely on exposure and because
paired comparisons between each intervention would have resulted in 21 follow-up tests for
each measure, we limited post-hoc comparisons to simple contrasts between exposure and the
remaining treatments. For the PRR, there was a significant within subjects effect, F (6, 954) =
240.05, p = .0001, partial 2 = .60, indicating that participants rated the interventions differently
in terms of their personal positive reactions. Simple contrasts indicated that participants rated
exposure more highly than each of the other treatments. For the CS, we again found a
significant effect for treatment type, F (6, 924) = 177.66, p = .0001, partial 2 = .54, and simple
contrasts indicated that exposure was rated as more credible than each of the other
interventions.
Analyses of PRR and CS scores in participants who reported a Criterion A event and
those who met self-report criteria for PTSD indicated an identical pattern as described above
with one exception. In the sample of participants who met criteria for PTSD (n = 11), the followup contrast analyses indicated no significant difference between exposure and CBT or exposure
and psychodynamic therapy on either the PRR or CS. It should be noted, however, that the lack
of significance appears to mostly be related to sample size. More specifically, the effect size of
the difference between PR ratings for exposure and PR ratings for CBT were virtually identical
in all three samples (total sample d = .68; Criterion A sample d = .74; PTSD sample d = .68).
1.3.4 Critical Thinking Scores
To examine the relationship between critical thinking and treatment choice, we recoded
patients based on their two most preferred therapies. Because it is hard to argue that
participants who choose exposure as their first therapy choice and CBT as their second should
meaningfully differ with respect to critical thinking compared to participants who choose CBT
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first and exposure second, we divided participants into two groups. Group 1 (n = 84) consisted
of participants who selected exposure, CBT, and/or sertraline for both of their top two choices.
These three treatments were described as having the most empirical support, which is the
reason we chose to cluster them.
We had planned on comparing Group 1 to participants who exclusively chose
interventions with limited empirical support (e.g., TFT, MTB) and to a group that chose a mix of
interventions. This was not possible, however, because review of participant choices indicated
that all participants selected at least one of the three most empirically supported treatment
options (i.e., exposure, CBT, and Sertraline) as their first or second choice. As noted above, no
participant selected EMDR for either their first or second choice. Thus second group (n = 76)
comprised of participants who chose one of the three treatments in Group 1 along with
psychodynamic treatment, TFT, or MTB.
As noted above, we hypothesized that participants who chose empirically supported
interventions would evidence greater critical thinking skills than those who did not. Because
both groups selected empirically supported interventions to some degree, we were unable to
submit this hypothesis to as robust a test as we would have preferred (i.e., compare participants
who chose no empirically supported interventions to those who did). Nonetheless, results of a
one-tailed t-test provided some support for our hypothesis. Participants in Group 1 had a higher
mean CTQ score (M = 18.82, SD = 3.03) compared to participants in Group 2 (M = 17.89, SD =
3.76), t (157) = 1.73, p = .04, Cohen’s d = .27.
1.3.5 Relationship between depression / anxiety and credibility / personal reaction scores
In order to facilitate comparison with the study by Zoellner et al. (2004), we correlated
BDI, state and trait anxiety scores with the CS and PRR scores. Using a Bonferroni correction
(p < .001), we found that trait anxiety was associated with higher positive personal reactions to
psychodynamic therapy (r = .28) and higher credibility scores (r = .27). No other correlations
approached significance.
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1.4 Discussion
The present study replicates findings from previous studies (i.e., Zoellner et al., 2003;
Feeny & Zoellner, 2004; Tarrier et al., 2006) and suggests that patients may be more receptive
to exposure for PTSD than indicated by current clinical practice utilization rates. Contrary to our
hypothesis, exposure remained the most preferred treatment choice even when participants had
the option of selecting more traditional psychotherapy (i.e., psychodynamic therapy), power
therapies, and medication. This finding also held when we examined participants who had
experienced a traumatic event. Although the percentage of participants ranking exposure as
their first choice treatment decreased somewhat when we only examined participants who met
self-report criteria for PTSD (from 51% to 36%), exposure still remained the most selected first
therapy choice. Furthermore, over 50% of this sub-sample selected it as one of their two most
preferred treatment options. Although the small sample size of the PTSD group limits the
conclusions that can be drawn, the consistency of results, both within this study and across the
three previous studies mentioned above, supports the interpretation that exposure may be
significantly more acceptable to patients than many therapists expect. Furthermore, the fact that
studies conducted in both the United States and United Kingdom, which have different health
care systems and means of paying for psychological services, have produced similar results
also suggests that results may point to the acceptability of exposure. Given that three of the
studies (including this one) have used analogue samples, however, further research is needed
with patient samples. This is particularly the case because one factor that may differentiate
those who develop PTSD from those who do not is a propensity for avoidance (Keane & Barlow,
2002). Individuals who are more inclined to use avoidance as a coping strategy may be
somewhat less inclined to pursue exposure secondary to their avoidant tendencies. Indeed, the
fact that our small sample of participants with PTSD showed a slight decrease in preference for
exposure compared to the total sample supports this concern. In addition, this sub sample
showed an increased interest in sertraline as a first choice treatment (19% compared to 9% for
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the total sample), an increase that mirrors that found by Zoellner et al. (22% in PTSD
subsample compared to 7% in total sample).
Results from the PRR and CS basically mirrored those for treatment choice. Participants
rated exposure as the most credible treatment and it also was associated with the most positive
personal reactions. These results held even when we only examined data from participants who
had experienced a traumatic event or participants who met criteria for PTSD.
Also consistent with the study by Tarrier et al. (2006), participants in the present study
showed considerable interest in CBT with a stronger cognitive restructuring focus, and a
surprising lack of interest in EMDR. Regarding participants’ ranking of CBT generally, exposure
and the cognitive restructuring intervention were the most consistently selected preferred
therapy choices. Tarrier et al. similarly found that four of the five most highly ranked treatments
were variants of cognitive restructuring and/or exposure and that the highest ranked treatment
was cognitive therapy. Results from both studies indicate that patients may find empirically
supported cognitive behavioral therapies for PTSD generally acceptable. Given the analogue
nature of these studies and the fact that exposure and cognitive therapy were highly rated in
both studies, we do not believe that the findings from these studies suggest a clear preference
for cognitive therapy over exposure or vice versa.
As noted above, participants showed little interest in EMDR. In fact, EMDR was the only
therapy not chosen by a single participant as either a first or second choice. This is interesting
for several reasons. First, although participants in this study showed little interest in EMDR,
EMDR appears to be a relatively popular treatment modality among clinicians (e.g., there is an
international association, conference, and journal devoted to EMDR). The lack of
correspondence between respondents in the present study and clinician interest in EMDR
suggests that, as with exposure, there may be a disconnection between patient and clinician
attitudes about PTSD interventions. Second, although it would be easy to dismiss this result as
a random finding, Tarrier et al. (2006) found that EMDR was the second lowest ranked therapy
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in their study. Thus, despite using different EMDR descriptions, both studies generated similar
results. Third, it could be argued that results for EMDR might indicate experimenter bias. Indeed
we fully admit that we have a preference for exposure and the other CBT intervention over
EMDR. We also, however, prefer the empirical support backing EMDR compared to that
available for psychodynamic therapy, TFT or MTB. Thus, our bias should have generated
rankings in which EMDR was preferred over those treatments. This was not, however, what we
found. Finally, although we attempted to keep the word counts similar, they were slightly
different for the different treatment descriptions. Thus, it could be argued that word count
influenced the decreased interest in EMDR given that it was associated with the lowest word
count. However, MTB was the second least preferred treatment, and was associated with the
highest word count. Furthermore, results from Tarrier et al. indicated that word length was not
associated with the acceptability of treatment. Thus, it seems unlikely that word count played a
significant role. In sum, we suggest that the EMDR finding, like that for exposure, may indicate a
potential real difference between therapist and patient perceptions about these therapies.
If the results of the four studies investigating patient (or analogue patient) attitudes to
PTSD treatments are correct in pointing to a possible misalignment of the PTSD treatments that
therapists are drawn towards and those that patients prefer, then it will be important to identify
why this is the case. For example, it may be that empirical support and a logical rationale
matters more to patients, who are looking for relief. Results from Tarrier et al. (2006) also
suggest that patients may be willing to endure anticipated discomfort if they believe that the
treatment will help them. In contrast, some therapists may shy away from therapies that they
perceive as requiring them to increase distress in patients, even if such interventions are
supported by both a logical rationale and data. For example, it appears that some therapists find
exposure unpalatable, regardless of the data that support the intervention. Rather, therapists
appear to have problems with the likelihood of producing discomfort in patients, possibly in the
form of exacerbated symptoms. More specifically, personal communications sent to this lab
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after the publication of the Becker et al. (2004) study indicate that some therapists believe that
straightforward exposure is “mean”; this perception is further supported by a popular press
article that labeled exposure as the “cruelest cure” and cited “one clinician” as saying that
exposure is “torture, plain and simple” (Slater, 2003). Thus, it may be fruitful to begin
researching strategies for changing therapist attitudes about exposure.
One novel exploratory aspect of the present study was the inclusion of a measure of
critical thinking skills. As noted above, Sharp and Herbert (2006) found that therapist critical
thinking skills were associated with greater use of EST techniques. The present study found that
patients who showed a greater interest in evidence based treatment, as indicated by choosing
ESTs for both top therapy choices, scored higher on a measure of critical thinking as compared
to those who chose a mix of empirically supported and alternate treatments. These studies
represent a preliminary inquiry into the role that critical thinking skills may play in therapy
preferences, particularly a preference for ESTs. As noted by Gambrill (2005), critical thinking is
associated with both scientific reasoning and evidence based practice. Thus, emerging findings
suggesting that ability to think critically may be associated with a preference for empirically
supported techniques should, perhaps, come as no surprise. Nonetheless, given the difficulties
encountered in disseminating ESTs into routine clinical practice, we suggest that it is important
to better understand all of the factors that may influence therapy preferences, both from the
perspective of a therapist and of a patient.
We were pleased to see relatively low interest in our intentionally absurd therapy, MTB.
We also were pleased by the fairly low interest in TFT, even though the use of TFT appears to
be alive and well in clinical practice. Two factors may account for this discrepancy. First, we
could be observing a problem with sample bias in this study given that all participants were
enrolled in a competitive university, which might elevate critical thinking skills generally and lead
to decreased interest in TFT. One argument against this explanation is the fact that the
participants’ CTQ scores ranged from 8 to 27, indicating marked variability in critical thinking
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skills. Alternatively, it may be that patients buy into TFT when it is sold to them by an invested
therapist, but might not select TFT if they were provided with a comprehensive set of treatment
options. This explanation would, once again, suggest that the underutilization of ESTs such as
exposure may be primarily driven by therapists not patients.
This study has a number of limitations, not the least of which is the use of an analogue
sample. It can be argued that results from an analogue sample may not generalize to clinical
populations; indeed, this is the reason that we encourage extension of this research with clinical
populations. It also should be noted, however, that results from Zoellner et al. (2003) did largely
generalize when the study was repeated with a clinical sample (Feeny & Zoellner, 2004). In
addition, results in this study were fairly consistent even when we examined sub-samples that
may be more similar to clinical populations. A second limitation relates to the actual treatment
descriptions. It could be argued that descriptions that included more detail about the level of
scientific support were stronger and, thus, that the study was biased. Theoretically, however,
patients in clinical practice should be accurately informed about the level of scientific support for
alternate treatments as part of informed consent. Thus, it did not appear to be accurate nor
make sense to claim that un-tested treatments had extensive empirical support.
In summary, the present study adds to a growing body of research suggesting that
exposure for PTSD may be an acceptable treatment option to many patients when they are
presented with a range of treatment choices and accurate information about the evidence
supporting the different interventions. The results from this study and previous research further
suggest that there may be a disconnection between treatments that appeal to therapists and
those that patients select. Future research is needed to better understand therapist attitudes
about exposure for PTSD given that therapists, not patients, may be a driving force behind
underutilization of this treatment in clinical practice.
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Table 1. Percent of participants who chose each therapy option as most or second most
preferred
Total Sample
(N = 160)

Criterion A
(n = 69)

PTSD
(n = 11)

Top Choice
(%)

Top 2
(%)

Top Choice
(%)

Top 2
(%)

Top Choice
(%)

Top 2
(%)

Exposure

50.6

71.3

50.7

66.7

36.4

54.6

CBT

21.9

58.1

17.4

53.6

27.3

63.6

Psychodynamic

15.6

38.1

15.9

39.1

18.2

54.6

Sertraline

8.8

23.8

11.6

24.6

18.2

27.3

TFT

2.5

6.9

2.9

8.7

0.0

0.0

MTB

0.6

1.9

1.4

4.3

0.0

0.0

EMDR

0.0

0.0

0.0

0.0

0.0

0.0

Note: Criterion A = all participants reporting lifetime occurrence of a criterion A event. PTSD =
all participants meeting full criteria for PTSD. CBT = Cognitive Behavioral Therapy. EMDR =
Eye Movement Desensitization Reprocessing. TFT = Thought-Field Therapy. MTB = My
Therapy Buddy.
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Table 2. Mean, standard deviation, and range on credibility scales, personal reactions to the
rationales, critical thinking questionnaires, and psychopathology measures

Measure

M

SD

Range

PRR – Exposure

27.36

4.13

15-35

PRR - CBT

23.85

6.04

7-35

PRR - Psychodynamic

22.29

7.00

7-35

PRR - Sertraline

15.54

5.77

5-31

PRR - TFT

14.00

6.21

5-32

PRR - EMDR

11.83

5.18

5-29

PRR - MTB

10.89

5.29

5-29

CS - Exposure

36.32

5.88

18-49

CS - CBT

32.89

7.91

9-47

CS – Psychodynamic

29.29

9.42

7-48

CS – Sertraline

26.66

8.79

7-48

CS – TFT

19.72

8.84

7-44

CS – EMDR

16.47

6.85

7-42

CS - MTB

16.19

7.75

7-37

CTQ

18.38

3.41

8-27

BDI-II

9.78

7.57

0-45

STAI State

37.71

10.37

20-67

STAI Trait

39.25

9.50

24-66

PDS symptom severitya

6.45

6.82

0-32

6.88%

N/A

N/A

PDS diagnosis
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Note: N = 160. a Symptom severity is calculated for those reporting a Criterion A event (n = 69).
CBT = cognitive behavioral therapy. EMDR = eye movement desensitization reprocessing. TFT
= thought-field therapy. MTB = my therapy buddy. CS = Credibility Scale. PRR = Personal
Reactions to the Rationale. CTQ = Critical Thinking Questionnaire. BDI-II = Beck Depression
Inventory – II, STAI = State-Trait Anxiety Inventory. PDS = Posttraumatic Diagnostic Scale.
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Appendix A
Prolonged Exposure (227 Words)
Prolonged Exposure (PE) is a 9-12 session individual therapy that has been shown to be
effective in the treatment of PTSD. Of the available psychotherapies used for PTSD, PE has
undergone some of the most rigorous scientific evaluation; results of several controlled studies
have shown it to significantly reduce PTSD symptoms, particularly in women. PE is a type of
cognitive behavioral treatment, which is designed to specifically target a number of traumarelated difficulties.
If you choose this treatment for PTSD, you will meet once a week with your therapist for
60-90 minutes. You will not receive medication for your PTSD symptoms. Procedures in this
treatment include: education about common reactions to trauma, breathing retraining (relaxation
training), prolonged (repeated) exposure to trauma memories, repeated in vivo (i.e., in real life)
exposure to situations that you are avoiding due to trauma-related fear. In other words, you will
be encouraged to confront the memory of your trauma through repeatedly telling the story to
your therapist and to confront things in your life that you are avoiding because they make you
afraid (e.g., driving a car, walking on the street at night). In this program, you will be assigned
“homework” to encourage you to practice in life the things you learn in therapy.
The risks associated with PE are mild to moderate discomfort when exposed to anxietyprovoking images, situations, and places.

Cognitive Behavioral Therapy (225 Words)
Cognitive behavioral therapy (CBT) is a treatment package developed for PTSD. CBT
can be conducted in individual or group format and is completed in 12 sessions. CBT has
undergone rigorous scientific evaluation and has been supported by clinical trials. An
assumption of CBT states that information about trauma is stored in ‘fear networks’ in the brain.
This network’s purpose is to stimulate future avoidance to prevent another experience of
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trauma; however, this network may be overactive and overly general in people experiencing
PTSD. Negative self statements perpetuate these ‘fear networks’. The goal of CBT is to process
emotions and confront beliefs about the trauma and its implications for present-day living.
If you choose CBT, you will complete weekly 90-minute individual therapy sessions.
You will not receive medication for your PTSD symptoms. You will be asked to write detailed
narratives of the traumatic event and will read the narratives aloud in session and for homework.
You will be provided basic education about feelings, given information about how selfstatements affect emotions, and are encouraged to identify ‘stuck points’ (improperly processed
emotions about the trauma) in your narrative and challenge improper beliefs about the trauma
such as self blame. By doing this, you will find and maintain a balanced, realistic perception of
the world.
Side effects of CBT include uncomfortable feelings and unsettling thoughts when
remembering the trauma.

Pharmological treatment – Zoloft (218 Words)
Zoloft (Setraline) is an antidepressant that has been shown to be effective in the
treatment of PTSD. Of the available medications used for PTSD, Zoloft has undergone some of
the most rigorous scientific evaluation; it is the only FDA approved medication for the treatment
of PTSD. Zoloft is a type of antidepressant called an SSRI, or, selective serotonin reuptake
inhibitor, which is designed to have fewer side effects than older antidepressants (e.g., MAOIs,
TCAs, SRIs).
If you choose this treatment for PTSD, you will take up to 200 mg of Zoloft daily for 10
weeks. In this treatment you will not talk extensively about your traumatic experience or be
encouraged to confront situations or places you are avoiding. You will be seen weekly by a
psychiatrist who will offer general encouragement and support, monitor your response to
medication, and record any side effects you are experiencing. Your medication will be adjusted
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according to a dosing schedule or as clinically indicated. At the end of 10 weeks, the medication
will be tapered (reduced) gradually to minimize the chance of withdrawal symptoms with
medication discontinuation.
The risks associated with Zoloft are mild to moderate side effects or withdrawal
symptoms. Possible side-effects include loose stools, sweating, nausea, headache, fatigue,
anorexia, weight loss or gain, sexual impairment, increased anxiety, restlessness, and
insomnia.

Eye Movement Desensitization and Reprocessing (216 Words)
Eye Movement Desensitization and Reprocessing (EMDR) is a complex form of
psychotherapy that borrows elements from other forms of therapy. Some research supports the
use of EMDR. EMDR proposes that focusing on external stimuli- such as a moving visual object
- promotes the processing of internal stimuli, such as traumatic memories. External stimuli may
include bilateral hand tapping or having your therapist move his\her finger back and forth in front
of your eyes.
If you choose EMDR, you will meet with a therapist for several sessions. Often the
number of sessions is quite limited. You will not receive medication for your PTSD symptoms.
You will identify the most vivid memory of your trauma and a negative belief. You will then
focus on the memory image while moving your eyes back and forth and following the therapist's
fingers. You will also need to monitor your body’s sensations. You will then be instructed to let
your mind wander and or go blank. You will then catalogue your minds activities. Your therapist
will then help you identify the next therapy target. You will also work on increasing positive
beliefs.
EMDR has generally been associated with positive outcomes, and may sometimes be
used in combination with other therapies. Risks include mental distress which can cause
adverse arousal of the body.
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Psychodynamic Therapy (230 Words)
Psychodynamic therapy has been used for over a century to treat traumatic symptoms.
The goal of psychodynamic therapy is to make sense of the context of your trauma, and to
make sense of defensive psychic processes that allow the unconscious to transform repressed
memories into pathological symptoms. Psychodynamic therapy generally has not been
rigorously evaluated in research trials because treatment tends to focus on psychic processes
as opposed to psychological symptoms.
If you chose psychodynamic psychotherapy you will meet individually with a therapist
who will help you work through the underlying issues so that you are able to understand the
meaning of your unconscious processes. You will not receive treatment for your PTSD
symptoms. The therapeutic relationship is a critical component of therapy, and this relationship
will help you learn how to manage with your intense emotions. You also will work to achieve a
balance between your subjective needs, the external demands of the world, and your traumatic
memories. Your therapist generally will maintain a neutral stance during therapy. In other words,
your therapist will not give you advice regarding what to do. Rather you will explore your
feelings and behaviors so that you can gain insight regarding your symptoms, which will
increase your awareness and allow you to better control your symptoms. Treatment may be
long term.
Side effects of psychodynamic psychotherapy may include uncomfortable feelings and
unsettling thoughts.

Thought-Field Therapy (226 Words)
Thought –Field therapy (TFT) is a treatment requiring only one, short session of therapy.
Thought-field therapy treats many conditions including PTSD, phobias, anxiety, depression,
arthritis pain, and insomnia. Although TFT has undergone few clinical trials, many people
maintain that the results seen in TFT speak for themselves. TFT states that acupressure points
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mediate energy flow in the body, and treatment using this approach focuses on balancing the
body’s energy system through reprocessing of memories while tapping the body’s meridians.
If you choose thought field therapy, you will meet once with a therapist for 20 minutes.
You will not receive medication for your PTSD symptoms. The session will begin by asking you
to concentrate on the specific trauma associated with your distress. You will then rate the
severity of distress, and, based on this rating, the therapist will ask you to tap your fingers on a
specific meridian point. A focusing of attention to the trauma will then allow a release of energy
through the previously blocked meridian. Results are seen immediately in relation to the
trauma’s ‘thought-field’. You will be asked to rate your distress throughout the session in order
to see results as they happen.
Few side effects of TFT have been documented other than initial discomfort in
remembering the traumatic event, and successful thought-field treatment has even been
correlated with improved heart rate variability.

My Therapy Buddy (238 Words)
My Therapy Buddy (MTB), a carefully researched transitional object, was designed to
facilitate the internalization of your maternal relationship. Use of MTB builds critical and long
lasting psychic structures which soothe you and overcome your traumatic experience. MTB is
based on the Winnicottian notion of the universal need for a transitional object. Research has
shown that transitional objects, such as MTB, significantly reduce depression and anxiety. MTB
does this by acting as a midpoint between receiving comfort from others and the internalizing of
maternal comfort. Although MTB was not specifically designed to treat trauma, the benefits of
MTB have been so apparent that they speak for themselves. Thus, the use of MTB has been
extended to the treatment of trauma.
If you choose this treatment for PTSD, you will rely on MTB whenever you feel anxious
or sad. You will not receive any medication for your PTSD symptoms. The motto of MTB is
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“everything is going to be alright.” You will use MTB in the privacy of your own home whenever
you need comfort and emotional support. By softly touching the left or right foot of MTB, you can
access the supportive words that one desires in a time of need. The gentle, huggable feel to
MTB also provides critical physical comfort as well. Through repeated use, MTB becomes a
vital soothing component that will facilitate the healing process.
The risks associated with MTB are minimal to none.

